Status
Conditions
Treatments
About
In the past decade, massive scale-up of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) have led to significant reductions in malaria mortality and morbidity. Nonetheless, malaria burden remains high, and a dozen countries in Africa show a trend of increasing malaria incidence over the past several years. The high malaria burden in many areas of Africa underscores the need to improve the effectiveness of intervention tools by optimizing first-line intervention tools and integrating newly approved products into control programs. Vector control is an important component of the national malaria control strategy in Africa. Because transmission settings and vector ecology vary among countries or among districts within a country, interventions that work in one setting may not work well in all settings. Malaria interventions should be adapted and re-adapted over time in response to evolving malaria risks and changing vector ecology and behavior. The central objective of this application is to design optimal adaptive combinations of vector control interventions to maximize reductions in malaria burden based on local malaria transmission risks, changing vector ecology, and available mix of interventions approved by the Ministry of Health in each target country. The central hypothesis is that an adaptive approach based on local malaria risk and changing vector ecology will lead to significant reductions in malaria incidence and transmission risk. The aim of this study is to use a cluster-randomized sequential, multiple assignment randomized trial (SMART) design to compare various vector control methods implemented by the Ministry of Health of Kenya in reducing malaria incidence and infection, and develop an optimal intervention strategy tailored toward to local epidemiological and vector conditions.
Full description
In the past decade, massive scale-up of long-lasting insecticide-treated nets (LLINs) and indoor residual spraying (IRS) in Africa have led to significant reductions in malaria mortality and mobility. However, current first-line interventions are not sufficient to eliminate malaria in most countries. The widespread use of pyrethroid insecticides has resulted in resistant vector populations, and high coverage of LLINs and IRS has led to increased outdoor human feeding behavior and resting behavior. These changes in vector ecology and behaviors have significantly limited the effectiveness of current first-line interventions that target indoor biting and resting mosquitoes. Furthermore, as a result of ecological changes and intervention measures, malaria risk in a locality is dynamic, and the utility of malaria intervention tools may vary as new tools are being approved and introduced and the cost of each tool differs among locations and over time. Such variations in malaria risk, vector ecology, and utility of intervention tools exemplify the need to develop optimal adaptive interventions tailored to local malaria risks, vector ecology and supply chains. The central objective of this application is to design optimal adaptive combinations of vector control interventions to maximize reductions in malaria burden based on local malaria transmission risks, changing vector ecology, and available mix of interventions approved by the Ministry of Health in each target country. The central hypothesis is that an adaptive approach based on local malaria risk and changing vector ecology will lead to significant reductions in malaria incidence and transmission risk. To accomplish this objective, the investigators propose the following three specific aims:
Malaria interventions adapted to rapidly changing malaria risk and vector ecologies are critically needed to improve the effectiveness of malaria control measures. This study will use new techniques, including machine learning and a novel cluster-randomized SMART design, to develop optimal adaptive malaria intervention strategies.
The investigators will use 84 clusters in Kisumu County in Western Kenya to conduct the trial. Since it is a sequential multiple assignment randomized trail, the trial will include several intervention stages. At each stage there will be different interventions. If an intervention is effective (i.e., yields an above threshold reduction in malaria incidence) at Stage 1, the intervention will be continued, otherwise, the intervention will be replaced by another one at Stage 2. The replacement intervention may be decided by different ways, e.g., an known effective intervention or an intervention determined by a machine learning algorithm. Since interventions in some clusters may be continued (i.e., effective) by next stage, other interventions may be replaced by different interventions, the number of interventions arms can vary from stage to stage. This is very different from ordinary cluster randomized trials. In this trial, the investigators planned to start with piperonyl butoxide (PBO) treated long-lasting insecticidal nets (PBO LLIN), indoor residual spraying with Actellic(R) insecticide, and using the routine LLIN intervention as control. Both Actellic IRS and PBO LLIN have been tested to be effective against pyrethroid resistant Anopheles malaria vectors and reduce clinical malaria. Therefore, the initial stage will have three arms, i.e., regular LLIN, PBO LLIN, and regular LLIN plus Actellic IRS. Since the investigators don't know if the effectiveness of these interventions in different clusters, the stage 2 interventions may include up to 7 arms, i.e., some arms may be split into two arms, based on the evaluation at the end of Stage 1 intervention.
The investigators will begin the trial with a two-year smaller scale trial using 36 cluster and randomly assign the three interventions, i.e., regular LLIN, PBO LLIN and regular LLIN plus Actellic IRS, into these 36 cluster, with 12 clusters for each intervention. This pre-trial trial is to determine the optimal way for conducting the full-scale 84 cluster trial, including operational and effectiveness evaluation procedures, as well as cost-effectiveness analysis. The full scale 84 cluster trial will be started by Year 3. The full trial will be started from fresh, i.e., the same three interventions will be randomly assigned to the 84 clusters with 28 clusters for each interventions. Clinical malaria will be monitored using a cohort active case surveillance, parasite prevalence and vector density will be monitored using cross-sectional samplings. The results of these surveillance at the end of Stage 1 trial will be used to evaluate the effectiveness of interventions at each cluster for the Stage 1 interventions. Stage 2 interventions will be determined for each cluster based on the above evaluations, e.g., continue the same intervention or replace the intervention with different ones.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Household inclusion criteria:
Study subjects inclusion criteria:
Household exclusion criteria:
Study subjects exclusion criteria:
• Participants not home on day of survey
Primary purpose
Allocation
Interventional model
Masking
122,872 participants in 7 patient groups, including a placebo group
Loading...
Central trial contact
Guiyun Yan, Ph.D.; Guiyun Yan
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal